Skip to main content

Table 6 Comparison of postreperfusion and postoperative outcomes in patients with and without postreperfusion hyperkalemia

From: Elevated effluent potassium concentrations predict the development of postreperfusion hyperkalemia in deceased liver transplantation: a retrospective cohort study

 

PRHK (n = 54)

no PRHK (n = 32)

P

sK+1 (mmol/L)

6.36 ± 0.57

4.77 ± 0.39

 < 0.001

sK+5 (mmol/L)

4.20 ± 0.96

3.36 ± 0.46

 < 0.001

Maximum percentage increase in sK+ after reperfusion (%)

51.61 ± 23.62

20.27 ± 13.88

 < 0.001

Significant arrhythmias (n)

36 (66.7%)

6 (18.8%)

 < 0.001

Cardiac arrest (n)

6 (11.1%)

1 (3.1%)

0.250

Severe PRS (n)

43 (79.6%)

18 (56.3%)

0.021

Ventilation time (hours)

3.8 (2.7–6.6)

4.0 (2.1–5.5)

0.834

Length of ICU stay (days)

3.0 (2.5–4.0)

3.4 (2.7–4.2)

0.444

Hospitalization time (days)

18.5 (15.0–27.0)

21.0 (17.0–25.8)

0.178

EAD (n)

32 (59.3%)

5 (15.6%)

 < 0.001

AKI (n)a

22 (43.1%)

18 (62.1%)

0.104

Re-operation (n)

4 (7.4%)

4 (12.5%)

0.432

In-hospital mortality (n)

2 (3.7%)

2 (6.3%)

0.626

  1. Data are presented as mean and standard deviation (SD), median (interquartile range), or n (%). AKI acute kidney injury, EAD early allograft dysfunction, ICU intensive care unit, PRHK postreperfusion hyperkalemia, PRS postreperfusion syndrome, sK+ serum potassium concentration, sK+1 serum potassium concentration at one minute following reperfusion, sK+5 serum potassium concentration at five minutes following reperfusion. aPatients with preoperative dialysis or serum creatinine ≥ 133 μmol/L were excluded